Meta-analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation

International Journal of Cardiology

Volumn 189, Issue 1, 2015, Pages 199-203

  Phan, Kevin ^a,b   Wang, Nelson ^b   Pison, Laurent ^c   Kumar, Narendra ^c   Hitos, Kerry ^a,b   Thomas, Stuart P ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Catheter ablation; Dabigatran; Systematic review; Thromboembolism; VKA; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; DABIGATRAN; WARFARIN; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; DATA BASE; DRUG EFFICACY; DRUG SAFETY; GROIN HEMATOMA; HEART TAMPONADE; HUMAN; INFORMATION RETRIEVAL; META ANALYSIS (TOPIC); PRIORITY JOURNAL; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; ADVERSE EFFECTS; META ANALYSIS; PERIOPERATIVE PERIOD; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; DABIGATRAN; HUMANS; PERIOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; WARFARIN;

EID: 84929376618     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.04.072     Document Type: Article

References (9)

1. T. Crawford, H. Oral, Current status and outcomes of catheter ablation for atrial fibrillation, Heart Rhythm. 6 (2009) S12-S17.
2. K. Kearney, R. Stephenson, K. Phan, W.Y. Chan, M.Y. Huang, T.D. Yan, A systematic review of surgical ablation versus catheter ablation for trial fibrillation, Ann. Cardiothorac. Surg. 3 (2014) 15-29.
3. P. Santangeli, L. Di Biase, R. Horton, J.D. Burkhardt, J. Sanchez, A. Al- Ahmad, R. Hongo, S. Beheiry, R. Bai, P. Mohanty, W.R. Lewis, A. Natale, Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis, Circ. Arrhythm. Electrophysiol. 5 (2012) 302-311.
4. C. Eitel, J. Koch, P. Sommer, S. John, S. Kircher, A. Bollmann, A. Arya, C. Piorkowski, G. Hindricks, Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation, Europace 15 (2013) 1587-1593.
5. S. Themistoclakis, A. Corrado, F.E. Marchlinski, P. Jais, E. Zado, A. Rossillo, et al., The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation, J. Am. Coll. Cardiol. 55 (8) (2010) 735-743.
6. Fiorenzo Gaita, Domenico Caponi, Martina Pianelli, Marco Scaglione, Elisabetta Toso, Federico Cesarani, Carlo Boffano, et al., Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation, Circulation 122 (17) (2010) 1667-1673.
7. R. Providência, J.-P. Albenque, S. Combes, A. Bouzeman, B. Casteigt, N. Combes, K. Narayanan, E. Marijon, S. Boveda, Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis, Heart 100 (2014) 324-335.
8. Raphael Marlu, et al., Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban, Thromb. Haemost. 108 (2) (2012) 217-224.
9. K. Phan, D.H. Tian, C. Cao, D. Black, T.D. Yan, Systematic review and meta-analysis: techniques and a guide for the academic surgeon, Ann. Cardiothorac. Surg. (2015)http://dx.doi.org/10.3978/j.issn.2225-319X.2015.02.04.